Search

UT Southwestern Medical Center has received an award from the Advanced Research Projects Agency for Health (ARPA-H) to develop livers using patients’ own cells and an innovative three-dimensional (3D) printing approach.

Yan Peng serves as founding Deputy Editor-in-Chief of JCTP Published on: January 26, 2026 Dr. Yan Peng is a professor of pathology with a subspecialty in breast pathology. The year 2025 marked her 20th anniversary with the Department of Pathology at UT Southwestern. Yan Peng serves as founding Deputy…

A consortium of government, industry, and nonprofit partners will fund gene therapy clinical trials for three different rare diseases at UT Southwestern Medical Center and Children’s Health, where scientists are working on gene therapies to treat neurodevelopmental disorders in children.

The arrival of warmer temperatures marks the return of a cherished summer activity: backyard grilling. A UT Southwestern Medical Center toxicologist offers some cautionary guidelines to help you and your guests avoid food poisoning.

The UT Southwestern medical student met with patients as part of the Hospital Elder Life Program (HELP), a joint effort between UTSW and the Hobson Wildenthal Honors College at the University of Texas at Dallas that sends student volunteers to help geriatric patients retain their cognitive skills and maintain their physical well-being during their hospital stay.

UT Southwestern Medical Center researchers have identified a gene called Lipe that appears to be pivotal to retinal health, with mutations spurring immune activation and retinal degeneration. This is important because the retina is responsible for detecting the light that is transformed into vision.

Obesity and older age are significant predictors of the severity of obstructive sleep apnea (OSA) in children, researchers at UT Southwestern and Children’s Health found.

Led by two UT Southwestern physicians, a team of researchers from 15 U.S. medical centers has performed the first analysis of a potentially game-changing drug to treat upper urinary tract urothelial cancers.

An experimental form of insulin administered just once a week was safe for patients with Type 2 diabetes and helped them maintain healthy blood sugar levels better than insulin injected daily, according to the results of a phase 3 clinical trial led by a UT Southwestern Medical Center researcher.

Cooling brain tumor cells to stop them from dividing without killing healthy cells extended the survival of glioblastoma (GBM) animal models dramatically in a study led by a UT Southwestern resident.